Research advances of epigenetics in biliary atresia

References:

1 Govindarajan KK.Biliary atresia: Where do we stand now?[J].World J Hepatol, 2016, 8(36):1593-1601.DOI:10.4254/wjh.v8.i36.1593.
2 Asai A, Miethke A, Bezerra JA.Pathogenesis of biliary atresia:defining biology to understand clinical phenotypes[J].Nat Rev Gastroenterol Hepatol, 2015, 12(6):342-352.DOI:10.1038/nrgastro.2015.74.
3 Mack CL, Feldman AG, Sokol RJ.Clues to the etiology of bile duct injury in biliary atresia[J].Semin Liver Dis, 2012, 32(4):307-316.DOI:10.1055/s-0032-1329899.
4 Olaizola P, Lee-law PY, Arbelaiz A, et al. MicroRNAs and extracellular vesicles in cholangiopathies[J].Biochim Biophys Acta Mol Basis Dis, 2018, 1864(4 Pt B):1293-1307.DOI:10.1016/j.bbadis.2017.06.026.
5 Hand NJ, Horner AM, Master ZR, et al. MicroRNA profiling identifies miR-29 as a regulator of disease-associated pathways in experimental biliary atresia[J].J Pediatr Gastroenterol Nutr, 2012, 54(2):186-192.DOI:10.1097/MPG.0b013e318244148b.
6 Xiao Y, Wang J, Yan W, et al. Dysregulated miR-124 and miR-200 expression contribute to cholangiocyte proliferation in the cholestatic liver by targeting IL-6/STAT3 signalling[J].J Hepatol, 2015, 62(4):889-896.DOI:10.1016/j.jhep.2014.10.033.
7 Bessho K, Shanmukhappa K, Sheridan R, et al. Integrative genomics identifies candidate microRNAs for pathogenesis of experimental biliary atresia[J].BMC Syst Biol, 2013, 7:104.DOI:10.1186/1752-0509-7-104.
8 De Carvalho E, Ivantes CA, Bezerra JA.Extrahepatic biliary atresia:current concepts and future directions[J].J Pediatr (Rio J), 2007, 83(2):105-120.DOI:10.2223/JPED.1608.
9 Hsu YA, Lin CH, Lin HJ, et al. Effect of microRNA-155 on the interferon-gamma signaling pathway in biliary atresia[J].Chin J Physiol, 2016, 59(6):315-322.DOI:10.4077/cjp.2016.Bae419.
10 Zhao R, Dong R, Yang Y, et al. MicroRNA-155 modulates bile duct inflammation by targeting the suppressor of cytokine signaling 1 in biliary atresia[J].Pediatr Res, 2017, 82(6):1007-1016.DOI:10.1038/pr.2017.87.
11 Li QJ, Chau J, Ebert PJ, et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection[J].Cell, 2007, 129(1):147-161.DOI:10.1016/j.cell.2007.03.008.
12 Diaz R, Kim JW, Hui JJ, et al. Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis[J].Hum Pathol, 2008, 39(1):102-115.DOI:10.1016/j.humpath.2007.05.021.
13 Shen W, Chen G, Dong R, et al. MicroRNA-21/PTEN/Akt axis in the fibrogenesis of biliary atresia[J].J Pediatr Surg, 2014, 49(12):1738-1741.DOI:10.1016/j.jpedsurg.2014.09.009.
14 Ye Y, Li Z, Feng Q, et al. Downregulation of microRNA-145 may contribute to liver fibrosis in biliary atresia by targeting ADD3[J].PLoS One, 2017, 12(9):e0180896.DOI:10.1371/journal.pone.0180896.
15 Dong R, Zheng Y, Chen G, et al. miR-222 overexpression may contribute to liver fibrosis in biliary atresia by targeting PPP2R2A[J].J Pediatr Gastroenterol Nutr, 2015, 60(1):84-90.DOI:10.1097/mpg.0000000000000573.
16 Xiao Y, Wang J, Chen Y, et al. Up-regulation of miR-200b in biliary atresia patients accelerates proliferation and migration of hepatic stallate cells by activating PI3K/Akt signaling[J].Cell Signal, 2014, 26(5):925-932.DOI:10.1016/j.cellsig.2014.01.003.
17 Zhao D, Luo Y, Xia Y, et al. MicroRNA-19b Expression in Human Biliary Atresia Specimens and Its Role in BA-Related Fibrosis[J].Dig Dis Sci, 2017, 62(3):689-698.DOI:10.1007/s10620-016-4411-z.
18 Shen WJ, Dong R, Chen G, et al. microRNA-222 modulates liver fibrosis in a murine model of biliary atresia[J].Biochem Biophys Res Commun, 2014, 446(1):155-159.DOI:10.1016/j.bbrc.2014.02.065.
19 Wang JY, Li ZH, Ye M, et al. Effect of miR-29c and miR-129-5p on epithelial-mesenchymal transition in experimental biliary atresia mouse models[J].Genet Mol Res, 2016, 15(3).DOI:10.4238/gmr.15037753.
20 Zahm AM, Hand NJ, Boateng LA, et al. Circulating microRNA is a biomarker of biliary atresia[J].J Pediatr Gastroenterol Nutr, 2012, 55(4):366-369.DOI:10.1097/MPG.0b013e318264e648.
21 Goldschmidt I, Thum T, Baumann U.Circulating miR-21 and miR-29a as Markers of Disease Severity and Etiology in Cholestatic Pediatric Liver Disease[J].J Clin Med, 2016, 5(3):28.DOI:10.3390/jcm5030028.
22 Dong R, Shen Z, Zheng C, et al. Serum microRNA microarray analysis identifies miR-4429 and miR-4689 are potential diagnostic biomarkers for biliary atresia[J].Sci Rep, 2016, 6:21084.DOI:10.1038/srep21084.
23 Peng X, Yang L, Liu H, et al. Identification of Circulating MicroRNAs in Biliary Atresia by Next-Generation Sequencing[J].J Pediatr Gastroenterol Nutr, 2016, 63(5):518-523.DOI:10.1097/mpg.0000000000001194.
24 Shan Y, Shen N, Han L, et al. MicroRNA-499 Rs3746444 polymorphism and biliary atresia[J].Dig Liver Dis, 2016, 48(4):423-428.DOI:10.1016/j.dld.2015.11.014.
25 Moore LD, Le T, Fan G.DNA methylation and its basic function[J].Neuropsychopharmacology, 2013, 38(1):23-38.DOI:10.1038/npp.2012.112.
26 Dong R, Zhao R, Zheng S.Changes in epigenetic regulation of CD4+ T lymphocytesin biliary atresia[J].Pediatr Res, 2011, 70(6):555-559.DOI:10.1203/PDR.0b013e318232a949.
27 Dong R, Zhao R, Zheng S, et al. Abnormal DNA methylation of ITGAL (CD11a) in CD4+ T cells from infants with biliary atresia[J].Biochem Biophys Res Commun, 2012, 417(3):986-990.DOI:10.1016/j.bbrc.2011.12.054.
28 Li K, Zhang X, Yang L, et al. Foxp3 promoter methylation impairs suppressive function of regulatory T cells in biliary atresia[J].Am J Physiol Gastrointest Liver Physiol, 2016, 311(6):G989-G997.DOI:10.1152/ajpgi.00032.2016.
29 Matthews RP, Eauclaire SF, Mugnier M, et al. DNA hypomethylation causes bile duct defects in zebrafish and is a distinguishing feature of infantile biliary atresia[J].Hepatology, 2011, 53(3):905-914.DOI:10.1002/hep.24106.
30 Cui S, Eauclaire SF, Matthews RP.Interferon-gamma directly mediates developmental biliary defects[J].Zebrafish, 2013, 10(2):177-183.DOI:10.1089/zeb.2012.0815.
31 Yang Y, Jin Z, Dong R, et al. MicroRNA-29b/142-5p contribute to the pathogenesis of biliary atresia by regulating the IFN-gamma gene[J].Cell Death Dis, 2018, 9(5):545.DOI:10.1038/s41419-018-0605-y.
32 Cofer ZC, Cui S, Eauclaire SF, et al. Methylation Microarray Studies Highlight PDGFA Expression as a Factor in Biliary Atresia[J].PLoS One, 2016, 11(3):e0151521.DOI:10.1371/journal.pone.0151521.
33 Udomsinprasert W, Kitkumthorn N, Mutirangura A, et al. Global methylation, oxidative stress, and relative telomere length in biliary atresia patients[J].Sci Rep, 2016, 6:26969.DOI:10.1038/srep26969.
34 Udomsinprasert W, Kitkumthorn N, Mutirangura A, et al. Association between Promoter Hypomethylation and Overexpression of Autotaxin with Outcome Parameters in Biliary Atresia[J].PLoS One, 2017, 12(1):e0169306.DOI:10.1371/journal.pone.0169306.
35 Kooistra SM, Helin K.Molecular mechanisms and potential functions of histone demethylases[J].Nat Rev Mol Cell Biol, 2012, 13(5):297-311.DOI:10.1038/nrm3327.
36 Emmett MJ, Lazar MA.Integrative regulation of physiology by histone deacetylase 3[J].Nat Rev Mol Cell Biol, 2019, 20(2):102-115.DOI:10.1038/s41580-018-0076-0.
37 Barbier-Torres L, Beraza N, Fernandez-Tussy P, et al. Histone deacetylase 4 promotes cholestatic liver injury in the absence of prohibitin-1[J].Hepatology, 2015, 62(4):1237-1248.DOI:10.1002/hep.27959.
38 Rinn JL, Chang HY.Genome regulation by long noncoding RNAs[J].Annu Rev Biochem, 2012, 81:145-166.DOI:10.1146/annurev-biochem-051410-092902.
39 Nuerzhati Y, Dong R, Song Z, et al. Role of the long noncoding RNAAnnexin A2 pseudogene 3/Annexin A2 signaling pathway in biliary atresiaassociated hepatic injury[J].Int J Mol Med, 2019, 43(2):739-748.DOI:10.3892/ijmm.2018.4023.
40 Zhang Y, Liu C, Barbier O, et al. Bcl2 is a critical regulator of bile acid homeostasis by dictating Shp and LncRNA H19 function[J].Sci Rep, 2016, 6:20559.DOI:10.1038/srep20559.
41 Li X, Liu R, Huang Z, et al. Cholangiocyte-derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans[J].Hepatology, 2018, 68(2):599-615.DOI:10.1002/hep.29838.
42 Xiao Y, Liu R, Li X, et al. Long Noncoding RNA H19 Contributes to Cholangiocyte Proliferation and Cholestatic Liver Fibrosis in Biliary Atresia[J].Hepatology, 2019, 70(5):1658-1673.DOI:10.1002/hep.30698.
43 Edupuganti RR, Geiger S, Lindeboom RGH, et al. N(6)-methyladenosine (m(6)A) recruits and repels proteins to regulate mRNA homeostasis[J].Nat Struct Mol Biol, 2017, 24(10):870-878.DOI:10.1038/nsmb.3462.
44 Liu N, Dai Q, Zheng G, et al. N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions[J].Nature, 2015, 518(7540):560-564.DOI:10.1038/nature14234.
45 Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges[J].Nature, 2013, 495(7441):384-388.DOI:10.1038/nature11993.
46 Rupaimoole R, Slack FJ.MicroRNA therapeutics:towards a new era for the management of cancer and other diseases[J].Nat Rev Drug Discov, 2017, 16(3):203-222.DOI:10.1038/nrd.2016.246.
47 Ozcan G, Ozpolat B, Coleman RL, et al. Preclinical and clinical development of siRNA-based therapeutics[J].Adv Drug Deliv Rev, 2015, 87:108-119.DOI:10.1016/j.addr.2015.01.007.
48 Zhang H, Pandey S, Travers M, et al. Targeting CDK9 Reactivates Epigenetically Silenced Genes in Cancer[J].Cell, 2018, 175(5):1244-1258.e1226.DOI:10.1016/j.cell.2018.09.051.
49 He Z, Yang D, Fan X, et al. The Roles and Mechanisms of LncRNAs in Liver Fibrosis[J].Int J Mol Sci, 2020, 21(4):1482.DOI:10.3390/ijms21041482.